ONUŠČÁKOVÁ, Magdaléna, Hana PÍŽOVÁ, Miroslav KEMKA, Vladimír GARAJ and Pavel BOBÁĽ. TARGETING METALLOENZYMES WITH NEWLY DESIGNED INHIBITORS FOR POTENTIAL THERAPEUTIC INTERVENTION. In SAL 2022 Brno. 2022.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name TARGETING METALLOENZYMES WITH NEWLY DESIGNED INHIBITORS FOR POTENTIAL THERAPEUTIC INTERVENTION
Authors ONUŠČÁKOVÁ, Magdaléna (703 Slovakia, guarantor, belonging to the institution), Hana PÍŽOVÁ (203 Czech Republic, belonging to the institution), Miroslav KEMKA (703 Slovakia), Vladimír GARAJ (703 Slovakia) and Pavel BOBÁĽ (703 Slovakia, belonging to the institution).
Edition SAL 2022 Brno, 2022.
Other information
Original language English
Type of outcome Presentations at conferences
Field of Study 30107 Medicinal chemistry
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14160/22:00126654
Organization unit Faculty of Pharmacy
Keywords in English metalloproteins_molecular docking_p-coumaric acid
Changed by Changed by: PharmDr. Magdaléna Onuščáková, učo 507453. Changed: 13/9/2022 14:21.
Abstract
Almost half of all enzymes must cooperate with metal ions to function. Most metalloproteins play a crucial role in metabolically essential processes. They also significantly impact the progression of various human diseases, including cancer, heart disease, and HIV/AIDS. Due to this reason, they are an attractive medical target for the treatment of a wide range of human disorders.
Links
MUNI/IGA/1339/2021, interní kód MUName: Design, synthesis and evaluation of potential metalloenzymes inhibitors (Acronym: DSEPMI)
Investor: Masaryk University
PrintDisplayed: 12/10/2024 08:19